| |
| |
|
| Insider
Information: |
De Rubertis Francesco |
| Relationship: |
Director |
| City: |
London |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
13,456,760 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
13,456,760 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Minerva Neurosciences, Inc. |
NERV |
Director, 10% Owner |
|
0 |
2016-12-12 |
4,690,906 |
Premium* |
|
|
Centessa Pharmaceuticals Plc |
CNTA |
Director |
|
0 |
2022-03-21 |
8,765,854 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CNTA |
Centessa Pharmaceuticals ... |
Director |
– • – |
2022-03-21 |
4 |
A |
$0.00 |
$0 |
I/I |
1,839,265 |
281,162 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Director |
– • – |
2021-12-02 |
4 |
B |
$12.82 |
$440,059 |
I/I |
34,326 |
93,526 |
2.1 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Director |
– • – |
2021-12-01 |
4 |
B |
$12.62 |
$761,036 |
I/I |
60,304 |
92,730 |
2.1 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Director |
– • – |
2021-11-30 |
4 |
B |
$11.62 |
$428,162 |
I/I |
36,847 |
91,331 |
2.1 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Director |
– • – |
2021-11-29 |
4 |
B |
$11.70 |
$663,477 |
I/I |
56,706 |
90,476 |
2.1 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Director |
– • – |
2021-11-26 |
4 |
B |
$11.34 |
$133,949 |
I/I |
11,817 |
89,161 |
2.1 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Director |
– • – |
2021-06-02 |
4 |
B |
$20.00 |
$12,000,000 |
I/I |
600,000 |
88,887 |
2.1 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
I/I |
1,931,818 |
74,964 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Director |
– • – |
2021-05-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
15,392,074 |
|
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • • |
2016-12-12 |
4 |
OE |
$5.77 |
$1,169,603 |
I/I |
202,634 |
4,690,906 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • • |
2016-08-10 |
4 |
S |
$10.00 |
$10,000,000 |
I/I |
(1,000,000) |
4,488,272 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • • |
2015-03-18 |
4 |
B |
$4.81 |
$974,670 |
I/I |
202,634 |
5,488,272 |
2.25 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • • |
2014-07-07 |
4 |
B |
$6.00 |
$9,724,998 |
I/I |
1,620,833 |
5,285,638 |
2.25 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • • |
2014-07-07 |
4 |
OE |
$6.00 |
$1,055,994 |
I/I |
175,999 |
3,664,805 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • • |
2014-06-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,436,898 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
